Related by context. Frequent words. (Click for all words.) 60 ATL# [001] 60 elotuzumab 58 eniluracil 57 apaziquone 57 outlicensing 56 Pennsaid R 56 Urocidin 56 AnGes 56 IND submission 56 Bicifadine 56 Nippon Kayaku 56 deforolimus 56 atacicept 55 phase IIb clinical 54 otelixizumab 54 Phase Ib clinical 54 methylnaltrexone 54 TOCOSOL Paclitaxel 54 Phase 1b clinical 53 Mipomersen 53 Uracyst R 53 BNC# 53 X Excite 53 GLPG# 52 BEMA Buprenorphine 52 ELND# 52 phase IIb 52 Strativa 52 Allovectin 7 R 52 Addrenex 52 Virulizin R 52 OncoMed 52 confirmatory Phase III 52 Affitech 52 Diamyd ® 51 BrachySil 51 Kyowa Hakko Kirin 51 BLA submission 51 cangrelor 51 orphan designation 51 BioSeek 51 PEG SN# 51 goserelin 51 Phenomix 51 Traficet EN 51 talactoferrin 51 PMA submission 51 bicifadine 51 Novexel 51 Asentar 51 rhThrombin 51 phase IIa 51 registrational 50 MONOVISC 50 Durect 50 CFFT 50 MIVT 50 DepoMed 50 Astex 50 StemEx 50 dose escalation 50 Lycera 50 NOXXON 50 Phase 1b 50 NEBIDO 50 Ono Pharmaceutical 49 Phase 2a trial 49 Plexxikon 49 Trubion Pharmaceuticals 49 celgosivir 49 drug conjugate ADC 49 isavuconazole 49 OMJPI 49 Phase IIa clinical trials 49 Alnara 49 Tolerx 49 Solzira 49 confirmatory Phase 3 49 FDA approvable letter 49 BioInvent 49 Laquinimod 49 nab paclitaxel 49 Paladin Labs 49 commercialization milestones 49 OLEPTRO TM 48 IND enabling 48 Phase 1a 48 Phase Ib 48 Orphan Drug designation 48 AZX# 48 BioVex 48 OXi# 48 BioDelivery Sciences 48 Zemiva 48 dirucotide 48 Flutiform 48 Ambrx 48 Licensing Agreements 48 IMC A# 47 CoGenesys 47 Exclusive License